4//SEC Filing
Ruffo Frank 4
Accession 0001209191-22-015809
CIK 0001557746other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:08 PM ET
Size
20.0 KB
Accession
0001209191-22-015809
Insider Transaction Report
Form 4
Ruffo Frank
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-03-01+8,300→ 206,409 total - Exercise/Conversion
Common Stock
2022-03-02+8,297→ 214,706 total - Award
Restricted stock units
2022-03-01+44,300→ 44,300 total→ Common Stock (44,300 underlying) - Exercise/Conversion
Restricted stock units
2022-03-01−25,750→ 25,750 total→ Common Stock (25,750 underlying) - Exercise/Conversion
Restricted stock units
2022-03-02−8,297→ 16,595 total→ Common Stock (8,297 underlying) - Award
Employee Stock Option (Right to Buy)
2022-03-01+155,200→ 155,200 totalExercise: $14.94Exp: 2032-02-29→ Common Stock (155,200 underlying) - Exercise/Conversion
Common Stock
2022-03-01+25,750→ 198,109 total - Exercise/Conversion
Restricted stock units
2022-03-01−8,300→ 24,900 total→ Common Stock (8,300 underlying)
Footnotes (6)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]Exercisable with respect to 25% of the shares subject to the option vesting in four equal annual installments beginning on March 1, 2023, subject to Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.
- [F3]The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2023, subject to the Reporting Person's continuous service as an officer with the issuer as of the applicable vesting date.
- [F4]The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.
- [F5]The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2022, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.
- [F6]The shares underlying these restricted stock units vest in four equal annual installments beginning on March 2, 2021, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654450
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:08 PM ET
- Size
- 20.0 KB